Success Metrics

Clinical Success Rate
72.4%

Based on 21 completed trials

Completion Rate
72%(21/29)
Active Trials
3(9%)
Results Posted
29%(6 trials)
Terminated
8(23%)

Phase Distribution

Ph early_phase_1
1
3%
Ph phase_2
8
23%
Ph phase_3
3
9%
Ph phase_1
17
49%
Ph not_applicable
2
6%
Ph phase_4
4
11%

Phase Distribution

18

Early Stage

8

Mid Stage

7

Late Stage

Phase Distribution35 total trials
Early Phase 1First-in-human
1(2.9%)
Phase 1Safety & dosage
17(48.6%)
Phase 2Efficacy & side effects
8(22.9%)
Phase 3Large-scale testing
3(8.6%)
Phase 4Post-market surveillance
4(11.4%)
N/ANon-phased studies
2(5.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

65.6%

21 of 32 finished

Non-Completion Rate

34.4%

11 ended early

Currently Active

3

trials recruiting

Total Trials

35

all time

Status Distribution
Active(3)
Completed(21)
Terminated(11)

Detailed Status

Completed21
Terminated8
Recruiting3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
35
Active
3
Success Rate
72.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.9%)
Phase 117 (48.6%)
Phase 28 (22.9%)
Phase 33 (8.6%)
Phase 44 (11.4%)
N/A2 (5.7%)

Trials by Status

recruiting39%
completed2160%
withdrawn39%
terminated823%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT07281781Phase 1

Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

Recruiting
NCT03256916Phase 3

Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

Completed
NCT06971744Phase 2

Autophagy Maintenance (AUTOMAIN)

Recruiting
NCT04169763Phase 1

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Recruiting
NCT02024009Phase 1

Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2

Completed
NCT01555281Phase 1

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Terminated
NCT01728779Phase 2

Stereotactic Body Radiation With Nelfinavir for Oligometastases

Completed
NCT01108666Phase 2

Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)

Terminated
NCT01925378Phase 2

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

Withdrawn
NCT02363829Phase 1

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Completed
NCT02066311Phase 2

Nelfinavir in Systemic Lupus Erythematosus

Terminated
NCT01445106Phase 1

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Completed
NCT00307502Phase 1

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Completed
NCT01065844Phase 2

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Completed
NCT00457665Phase 4

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Completed
NCT02188537Phase 2

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

Completed
NCT01020292Phase 1

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Completed
NCT00205283Not Applicable

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

Completed
NCT01086332Phase 1

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Terminated
NCT03422874Phase 1

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
35